BACKGROUND: Levodopa induced dyskinesias (LID) are a common problem which ultimately limit the effective treatment of patients with Parkinson's disease (PD). There is accumulating evidence that LID develop due to abnormal synaptic plasticity, which is in turn influenced by the release of brain derived neurotrophic factor (BDNF). METHODS: The influence of a common functional polymorphism of the BDNF gene on the risk of developing dyskinesias in a large cohort of patients with PD (n = 315), who were independently and variably treated with levodopa and/or other dopaminergic treatments, was investigated. RESULTS: Patients with the met allele of BDNF, associated with lower activity dependent secretion of BDNF, were at significantly higher risk of developing dyskinesias earlier in the course of treatment with dopaminergic agents (hazard ratio for each additional met allele 2.12, p = 0.001), which persisted following adjustment for potential confounding variables. CONCLUSION: This functional polymorphism may help predict which individuals are most at risk of LID and is consistent with the known actions of BDNF on synaptic plasticity in the striatum.
BACKGROUND:Levodopa induced dyskinesias (LID) are a common problem which ultimately limit the effective treatment of patients with Parkinson's disease (PD). There is accumulating evidence that LID develop due to abnormal synaptic plasticity, which is in turn influenced by the release of brain derived neurotrophic factor (BDNF). METHODS: The influence of a common functional polymorphism of the BDNF gene on the risk of developing dyskinesias in a large cohort of patients with PD (n = 315), who were independently and variably treated with levodopa and/or other dopaminergic treatments, was investigated. RESULTS:Patients with the met allele of BDNF, associated with lower activity dependent secretion of BDNF, were at significantly higher risk of developing dyskinesias earlier in the course of treatment with dopaminergic agents (hazard ratio for each additional met allele 2.12, p = 0.001), which persisted following adjustment for potential confounding variables. CONCLUSION: This functional polymorphism may help predict which individuals are most at risk of LID and is consistent with the known actions of BDNF on synaptic plasticity in the striatum.
Authors: Christoph van Thriel; Remco H S Westerink; Christian Beste; Ambuja S Bale; Pamela J Lein; Marcel Leist Journal: Neurotoxicology Date: 2011-10-12 Impact factor: 4.294
Authors: Josh D Woolley; Eric V Strobl; Wendy B Shelly; Anna M Karydas; R N Robin Ketelle; Owen M Wolkowitz; Bruce L Miller; Katherine P Rankin Journal: Curr Alzheimer Res Date: 2012-09 Impact factor: 3.498
Authors: Michael Baer; Bradley Klemetson; Diana Scott; Andrew S Murtishaw; James W Navalta; Jefferson W Kinney; Merrill R Landers Journal: J Neurol Phys Ther Date: 2018-04 Impact factor: 3.649
Authors: D Luke Fischer; Peggy Auinger; John L Goudreau; Allyson Cole-Strauss; Karl Kieburtz; Jordan J Elm; Mallory L Hacker; P David Charles; Jack W Lipton; Barbara A Pickut; Caryl E Sortwell Journal: Neurotherapeutics Date: 2020-11-19 Impact factor: 7.620
Authors: Rashed Harun; Kristin M Hare; Elizabeth M Brough; Miranda J Munoz; Christine M Grassi; Gonzalo E Torres; Anthony A Grace; Amy K Wagner Journal: J Neurochem Date: 2016-01-13 Impact factor: 5.372